期刊文献+

5-羟色胺能基因与SSRI类药物疗效的遗传药理学研究进展

暂未订购
导出
摘要 本文就5-HT系统的基因多态性与SSRI类抗抑郁药物的疗效之间的关系作一综述。
出处 《精神医学杂志》 2009年第6期468-471,共4页 Journal of Psychiatry
  • 相关文献

参考文献21

  • 1Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps : a STAR * D report [ J ]. Am J Psychiatry ,2006,163 ( 11 ) : 1905 - 1917.
  • 2Thase ME, Haight BR, Richard N, et al. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta - analysis of original data from 7 randomized controlled trials [ J ]. J Clin Psychiatry , 2005 ,66(8) :974 -981.
  • 3Shishkina GT, Kalinina TS, Dygalo NN. Up - regulation of tryptophan hydroxylase -2 mRNA in the rat brain by chronic fluoxetine treatment correlates with its antidepressant effect [J]. Neuroscience, 2007 ,150(2) :404 -412.
  • 4Serretti A, Zanardi R, Rossini D, et al. Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity[ J]. Mol Psychiatry ,2001 ,6 (5) : 586 - 592.
  • 5Serretti A, Zanardi R, Cusin C, et al Tryptophan hydroxylase gene associated with paroxetine antidepressant activity [ J ]. Eur Neuropsychopharmacol ,2001,11 ( 5 ) :375 - 380.
  • 6Ham B J, Lee BC, Paik JW, et al. Association between the tryptophan hydroxylase - 1 gene A218C pol):morphism and citalopram antidepressant response in a Korean population[ J ]. Prog Neuropsychopharmacol Biol Psychiatry , 2007 , 30; 31 (1) :104 - 107.
  • 7Yoshida K, Naito S, Takahashi H, et al. Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder[ J]. Prog Neuropsychopharmacol Biol Psychiatry, 2002 ,26 (7 - 8) : 1279 - 1283.
  • 8Durham LK, Webb SM, Milos PM, et al The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder[ J ]. Psychopharmacology (Berl) ,2004 , 174(4) :525 -529.
  • 9Murphy GM, Jr. , Hollander SB, Rodrigues HE, et al. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression [ J ]. Arch Gen Psychiatry, 2004 , 61 (11) :1163 -1169.
  • 10Hu XZ, Rush A J, Charney D, et al. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression [J]. Arch Gen Psychiatry, 2007 ,64(7) :783 -792.

二级参考文献8

  • 1Oquendo MA,Mann JJ.The biology of impulsivity and suicidality[J].Psychiatr Clin North Am,2000,23:11-25.
  • 2井上猛 小山司.难治性うっ病の治疗—ゎが国にぉける现状と治疗ァルゴリズム—[J].精神医学,1997,39:6-14.
  • 3Yasuhiro Inayamo,Hiroshi Yoneda,Toshiaki Sakai,et al.Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia[J].Am J Med Gen (neuropsychiatric genetice),1996,67:103.
  • 4井上猛,小山司. 三环系.四环系抗うっ药に治疗抵抗性うっ病の定义の妥当性に关する研究-第二选择の三环系.四环系抗うっ药への变更は有效な治疗战略か-[J].临床精神医学,1997,26:1603-1607.
  • 5Yuan X,Yamada K,Ishiyama-Shigemoto S,et al.Identification of polymorphic Ioci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes[J].Diabetologia,2000,43:373-376.
  • 6Marek GJ,Carpenter LL,McDougle CJ,et al.Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders[J].Neuropsychopharmacology,2003,28:402-412.
  • 7张晓斌,张志珺,侯钢,姚辉,张心保,沙维伟.5-羟色胺2C受体基因启动子区多态性与迟发性运动障碍的关联分析[J].中华精神科杂志,2002,35(4):198-201. 被引量:7
  • 8蔡军,陆峥,江三多,李霞,汪栋祥,姚培芬,熊祥玉.5-羟色胺2A受体基因多态性与抑郁症的关联[J].临床精神医学杂志,2004,14(3):129-130. 被引量:10

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部